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Abstract
A relationship between handedness and clinicodemographic profiles of people with multiple sclerosis
was sought using data from the Multiple Sclerosis Partners Advancing Technology Health Solutions
network of 10 multiple sclerosis centers in the USA and Europe. Handedness data were available for
8888 multiple sclerosis patients, of which 917 (10.3%) were left-handed. Clinicodemographic profiles of
right versus left-handed multiple sclerosis patients were similar except for a slightly increased proportion of men who were left-handed, and slightly reduced performance on the manual dexterity test using
the non-dominant hand in left-handed patients. We found no evidence to suggest a prognostic implication of handedness in multiple sclerosis.
Keywords: Multiple sclerosis, handedness, epidemiology
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Introduction
The relationship between handedness and autoimmune diseases such as multiple sclerosis (MS) is
debated.1–3 A previous study of female US nurses
suggested a modest increase in the risk of MS among
left-handed women.1 It has also been proposed that
HLA-alleles associated with an increased risk of MS
and circulating autoantibodies may be more
common among left-handed individuals.4
Approximately 11% of the general population is
left-handed.5 Few population-based studies have
examined the relationship between handedness and
demographic or clinical characteristics of people
with MS (PwMS). Multiple Sclerosis Partners
Advancing Technology Health Solutions (MS
PATHS)6 is a collaborative network including 10
MS centers in the USA and Europe and provides
access to a large cohort of PwMS. In this study,
we investigated the association between handedness
and clinicodemographic profile of enrollees in
MS PATHS.

Methods
This cross-sectional study utilized data from the MS
PATHS network. MS PATHS is a collaborative network sponsored by Biogen which includes seven
centers in the USA and three centers in Europe,
and is based on the concept of a learning health
system.6 During routine clinic visits, people with
MS undergo the multiple sclerosis performance test
(MSPT) which is an iPad-based assessment including structured patient history, electronic adaptations
of the multiple sclerosis functional composite, and
the neuro-quality of life (neuro-QoL) outcome
instrument.7
We queried MS PATHS for PwMS recruited from
the inception of the database (11/2015) through
3/2018. Requested variables included sex, age at
MS onset and diagnosis, MS subtype, level of education, handedness, patient determined disease steps
(PDDS) and relevant components of MSPT assessment including manual dexterity test (MDT), walking speed time (WST), contrast sensitivity test
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(CST), processing speed time (PST), and the NeuroQoL’s upper extremity function and cognitive
domains. Handedness data in MS PATHS is systematically collected by asking the patients which hand
they learned to write with.
We compared right and left-handed patients for differences in demographic and clinical profiles using
the chi-square test to examine the association
between categorical variables, t-test for continuous
variables, and Mann–Whitney U test for ordinal variables. P values less than 0.05 were considered statistically significant. The institutional review board
at Washington University in St Louis approved
the study.
Results
A total of 9618 PwMS were identified (73.2%
women). Handedness data were available for 8888
patients, of which 917 (10.3%) were left-handed.
Table 1 shows the demographic and clinical profiles
of the patients. Among women with MS, 9.5% were
left-handed whereas 12.4% of men with MS were
left-handed. Women comprised a greater proportion
of right-handed than of left-handed PwMS (74.0%
vs. 67.8%, P < 0.001). Overall, right and lefthanded patients had a similar age at MS diagnosis,
PDDS, and MS subtype. Approximately 65% of
PwMS had relapsing–remitting MS in both handedness groups. The mean time to complete MDT with
the left hand was not associated with handedness.
The mean time to complete MDT with the right
hand was slightly longer in left-handed compared
to right-handed PwMS (28.9  8.3 vs. 27.6  7.6
seconds, P<0.001). Results for WST, CST, PST,
and neuro-QoL upper extremity and cognitive
domain scores were similar between right and lefthanded PwMS. Stratification by sex did not change
our findings.
To examine if any major underlying upper extremity
dysfunction might have impacted our findings (by
affecting patient-reported handedness), we performed a sensitivity analysis by including a subset
of patients whose MDT performance values were in
the best performance quartile (<23 seconds) thus
having minimal functional impairment of upper
extremities. In this subset (n=1393, 10.1% lefthanded), the meanSD time to complete MDT
with the dominant hand was 20.01.7 seconds for
right-handed patients and 20.01.8 in left-handed
patients. Time to complete MDT with the non-dominant hand was 20.81.6 in right-handed patients,
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and 20.01.8 in left-handed patients. These results
did not change our interpretation of the findings.
We also investigated if right-handed and left-handed
patients might have been differentially impacted
when MDT performance is more severely impaired.
To examine this, we performed another sensitivity
analysis by including a subset of patients whose
MDT performance values were in the worst performance quartile (>32 seconds). In this subset
(n=1184, 10.1% left-handed), the meanSD time
to complete MDT with the dominant hand was
40.66.4 seconds for right-handed patients and
40.36.2 for left-handed patients. Time to complete
MDT with the non-dominant hand was 38.96.2 in
right-handed patients, and 40.06.8 in left-handed
patients. These results did not change our interpretation of the findings, either.
Discussion
In this large cross-sectional study using data from
MS PATHS, 10.3% of PwMS were left-handed,
close to the estimated 11% prevalence of lefthandedness or mixed-handedness in the US general
population.5 The higher prevalence of lefthandedness among male PwMS compared to
women (12.4% vs. 9.5%) in our study is consistent
with the general population. A meta-analysis found a
higher prevalence of left-handedness in men in the
general population, with an estimated male to female
odds ratio of 1.23 (95% confidence interval (CI)
1.19–1.27).8
A previous cohort study using data from the
Nurses’ Health Study reported a 62% increased
risk of MS among women who were naturally
left-handed as compared to those who were righthanded (relative risk=1.62, 95% CI 1.04–2.53)1
and suggested that prenatal exposure to sex hormones may possibly play a role in MS risk.9,10
That study included only women, and was not
designed to examine the clinical characteristics of
incident MS cases. We compared the clinical profiles of right versus left-handed PwMS to seek any
evidence to support that left-handed MS patients
may have an earlier MS onset or altered clinical
severity. No strong evidence to suggest this was
found. However, we found a slightly longer mean
time to complete MDT with the non-dominant hand
(right hand) in left-handed PwMS. The mean time
to complete MDT with the left hand was similar
between right-handed and left-handed MS patients.
The mean age at MS onset in left-handed
PwMS was minimally higher than right-handed

www.sagepub.com/msjetc

Shirani et al.

Table 1. Demographic and clinical profile of right-handed versus left-handed patients with MS (n ¼ 8888).
Characteristics
Sex,a n (%)
Women
Men
Age at MS symptom onset,c years, mean  SD
Age at MS diagnosis, years, mean  SD
Education,f years, median (IQR)
Disease subtype,h n (%)
Relapsing–remitting
Secondary progressive
Primary progressive
Progressive relapsing
Patient determined disease steps,i median (IQR)
Manual dexterity test for right hand,j seconds, mean  SD
Manual dexterity test for left hand,k seconds, mean  SD
Neuro-QoLl upper extremity function t-score,m mean  SD
Walking speed time,n seconds, mean  SD
Contrast sensitivity testo at high (100%) contrast,p mean  SD
Contrast sensitivity testo at low (2.5%) contrast,p mean  SD
Processing speed test,q seconds, mean  SD
Neuro-QoLl cognitive function t-score,m mean  SD

Right-handed
(n ¼ 7971)

Left-handed
(n ¼ 917)

5898 (74.0)
2068 (25.9)
32.3  11.2
35.2  11.0
14 (12–16)

622 (67.8)
294 (32.1)
32.6  11.8
35.6  11.5
14 (12–16)

4764 (64.3)
1381 (18.6)
595 (8.0)
665 (9.0)
1 (0–3)
27.6  7.6
29.0  7.7
45.5  9.5
7.4  4.9
57.0  6.3
33.7  13.0
46.9  12.9
46.2  9.1

549 (65.5)
164 (19.6)
50 (6.0)
75 (8.9)
1 (0–3)
28.9  8.3
28.7  8.0
45.1  9.5
7.7  5.2
56.6  6.1
32.9  13.5
46.6  12.9
45.6  8.9

P value
<0.001b
0.008d
0.066d
0.068g
0.20b

0.279g
<0.001d
0.333d
0.95d
0.187d
0.248d
0.174d
0.613d
0.91d

a

Data for sex were missing for six patients.
Chi-square test
c
Data for age at MS symptoms onset were missing for 414 patients.
d
Student’s t-test
e
Date for age at MS diagnosis were missing for 538 patients.
f
Data for education were missing for 310 patients.
g
Mann–Whitney U test.
h
Data for MS disease subtype were missing for 645 patients.
i
Data for patient determined disease steps were missing for 75 patients.
j
Data for manual dexterity test for the right hand were missing for 890 patients.
k
Data for manual dexterity test for the left hand were missing for 922 patients.
l
Scores for neuro-quality of life (Neuro-QoL) are reported using a t distribution, with the mean of the reference population set to 50 and the
standard deviation set to 10 units. Lower t scores indicate less of the concept being measured. For instance, a t score of 45 for upper extremity
function, is 0.5 standard deviation worse than the average.
m
Data for Neuro-QoL were missing for 2083 patients.
n
Data for walking speed time were missing for 1068 patients.
o
The contrast sensitivity testing is based on the Sloan low contrast letter acuity test and evaluates binocular acuity with a maximum number
correct of 60 at high (100%) and low (2.5%) contrast.
p
Data for contrast sensitivity test were missing for 3814 patients.
q
Data for processing speed test were missing for 625 patients.
b

PwMS. The implications of these subtle differences
are unclear.
We were unable to examine the relationship between
handedness and MS onset symptom laterality
because MS PATHS does not capture the details of
onset symptoms. Future studies should examine this
potential relationship, given that the brain networks
responsible for controlling the less dexterous
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non-dominant hand may have a lower reserve capacity, and therefore impairments of the fine motor control of the non-dominant hand may be discernable at
an earlier stage of MS.
Overall, we found no evidence to suggest a prognostic implication of handedness in MS. Our study also
encourages using MS PATHS for conducting clinical research in MS.
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